MetaCap

Cabaletta Bio Insider Trades

NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.9361-0.0739 (-7.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
8 · $296.19K
Sales
0 · $0
Shares bought / sold
132.07K / 0
Net activity
Net buying $296,189

Cabaletta Bio insider activity

Over the last 12 months, Cabaletta Bio insiders reported 8 transactions on SEC Form 4: 8 open-market purchases and 0 sales. Insiders bought $296,189 and sold $0 worth of stock, for net insider buying of $296,189. The most recent filing shows Tomasello Shawn (Director) buying 22,725 shares at $2.21 on Jan 21, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CABA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CABA insider transactions

Cabaletta Bio insider transactions
DateInsiderTypeSharesValueFiling
Jan 21, 2026Gerard MichaelGeneral CounselBuy6,600$14.98KForm 4
Jan 21, 2026Simon MarkDirectorBuy11,061$25.26KForm 4
Jan 21, 2026Binder GwendolynPresident, Science & Tech.Buy11,312$24.76KForm 4
Jan 21, 2026Nichtberger StevenPresident & CEOBuy45,000$100.78KForm 4
Jan 21, 2026Bollard CatherineDirectorBuy4,405$9.98KForm 4
Jan 21, 2026Chang David J.Chief Medical OfficerBuy8,800$19.89KForm 4
Jan 21, 2026Gavel SteveChief Commercial OfficerBuy22,170$50.22KForm 4
Jan 21, 2026Tomasello ShawnDirectorBuy22,725$50.32KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related